作者: CF Adriaenssen
DOI: 10.1177/030006059802600506
关键词:
摘要: The activity, safety and tolerability of the azalide azithromycin were compared with those co-amoxiclav in treatment acute periapical abscesses adults an open, randomized, multicentre comparative study. Patients either sex, recruited from 106 dental practices Belgium, aged between 18 75 years had not requiring drainage, confirmed by radiology. Azithromycin was administered as a 500-mg tablet orally once daily for 3 days (n = 150) 625-mg capsule three times daily, 5-10 153). Both before after treatment, masticatory pain, percussion headache, oedema redness soft tissue graded on four-point scale. Overall clinical success (cure plus improvement) seen 131/144 (91%) evaluable patients receiving 142/148 (96%) (difference significant). There no significant difference two groups incidence or severity adverse events number discontinuations because events.